Time to Bet Against VIX After Recent Rising Streak, History Says

image

(Bloomberg) — Seven straight jumps in the so-called “fear gauge” for the S&P 500 is a signal that it may be time to wager against volatility, if history is any guide.

Only 10 times in the past two decades has the Cboe Volatility Index — better known as the VIX — risen for that many trading sessions in a row. Investors who shorted the gauge after the previous nine streaks of that length would have earned a return of nearly 19% after 20 days, according to data compiled by Bloomberg.

The most-recent round of stair-stepped volatility increases ran from Jan. 18 to Jan. 26, when the Federal Reserve had its latest policy meeting. The VIX fell the following day, signaling more clarity and, seemingly, less fear about interest rates and yields.

The Fed’s hawkish pivot to fight inflation has triggered a selloff in stocks on worries about receding stimulus and the risk of slower economic growth. Some Wall Street strategists now argue it’s time to buy the dip, which usually means volatility should ebb, too.

“The market may continue to slide, but we think so will volatility as volatility exhaustion is setting in,” Michael Purves, chief executive officer of Tallbacken Capital Advisors LLC, wrote in a note the day before the Fed meeting.

Another technical indicator comes up with a similar result: The VIX put/call ratio reached its highest level since October on Wednesday, according to Chris Murphy, derivatives strategist at Susquehanna International Group.

That gauge’s level could end up being a “peak,” he said, noting that similar readings were strongly bullish signals for the S&P 500. Among the 16 peaks that were higher than this week’s, the S&P 500 was higher a month later 13 times, with an average 4.2% gain, Murphy said.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More